Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Research & Development: 2019-2024

Historic Research & Development for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to $152.4 million.

  • Praxis Precision Medicines' Research & Development rose 57.10% to $65.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.9 million, marking a year-over-year increase of 114.73%. This contributed to the annual value of $152.4 million for FY2024, which is 75.66% up from last year.
  • Per Praxis Precision Medicines' latest filing, its Research & Development stood at $152.4 million for FY2024, which was up 75.66% from $86.8 million recorded in FY2023.
  • Over the past 5 years, Praxis Precision Medicines' Research & Development peaked at $155.0 million during FY2022, and registered a low of $45.0 million during FY2020.
  • For the 3-year period, Praxis Precision Medicines' Research & Development averaged around $131.4 million, with its median value being $152.4 million (2024).
  • Per our database at Business Quant, Praxis Precision Medicines' Research & Development skyrocketed by 167.38% in 2021 and then plummeted by 44.04% in 2023.
  • Praxis Precision Medicines' Research & Development (Yearly) stood at $45.0 million in 2020, then soared by 167.38% to $120.3 million in 2021, then grew by 28.92% to $155.0 million in 2022, then plummeted by 44.04% to $86.8 million in 2023, then surged by 75.66% to $152.4 million in 2024.